Validation of the Clinical Performance of HemosIL CL Anti-Cardiolipin IgG & IgM assays HemosIL CL Anti-B2 Glycoprotein-I IgG & IgM assays and HemosIL Multi-Ab Controls-Performance Evaluation Matrix Comparison on the SCL TOP 970 CL Matrix Comparison: Fresh vs Frozen
-
- STATUS
- Not Recruiting
Summary
The purpose of this study is to demonstrate there is no statistically significant difference in the result of plasma samples when analyzed fresh and the results afrer one (1) and two (2) freeze/thaw cycles on the ACL TOP 970 CL analyzer with the following assays:
- HemosIL CL Anit-Cardiolipin IgG
- HemosIL CL Anti-Cardiolipin IgM
- HemosIL CL Anti-B2 Glycoproteitin-I IgG
- HemosIL CL Anti-B2 Glycoprotein-I IgM
Description
The purpose of this study is to demonstrate there is no statistically significant difference in the result of plasma samples when analyzed fresh and the results afrer one (1) and two (2) freeze/thaw cycles on the ACL TOP 970 CL analyzer with the following assays:
- HemosIL CL Anit-Cardiolipin IgG
- HemosIL CL Anti-Cardiolipin IgM
- HemosIL CL Anti-B2 Glycoproteitin-I IgG
- HemosIL CL Anti-B2 Glycoprotein-I IgM
Details
| Age | 100years or below |
|---|---|
| Clinical Study Identifier | TX9381 |
| Last Modified on | 19 February 2024 |
Similar trials to consider
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteerStudy Definition
WikipediaAdd a private note
- Select a piece of text.
- Add notes visible only to you.
- Send it to people through a passcode protected link.